XML 35 R20.htm IDEA: XBRL DOCUMENT
v3.8.0.1

STOCK BASED COMPENSATION. | 12 Months Ended
--- | ---
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
STOCK-BASED COMPENSATION. |
| 13. | STOCK-BASED COMPENSATION.
The Company has two equity incentive compensation plans: a 2006 Stock Incentive Plan and a 2016 Stock Incentive Plan. 2006 Stock Incentive Plan – The 2006 Stock Incentive Plan authorized the issuance of incentive stock options (“ISOs”) and non-qualified stock options (“NQOs”), restricted stock, restricted stock units, stock appreciation rights, direct stock issuances and other stock-based awards to the Company’s officers, directors or key employees or to consultants that do business with the Company for up to an aggregate of 1,715,000 shares of common stock. In June 2016, this plan was terminated, except to the extent of issued and outstanding unvested stock awards and options. 2016 Stock Incentive Plan – On June 16, 2016, the Company’s shareholders approved the 2016 Stock Incentive Plan, which authorizes the issuance of ISOs, NQOs, restricted stock, restricted stock units, stock appreciation rights, direct stock issuances and other stock-based awards to the Company’s officers, directors or key employees or to consultants that do business with the Company for up to an aggregate of 1,150,000 shares of common stock. Stock Options – Summaries of the status of Company’s stock option plans as of December 31, 2017 and 2016 and of changes in options outstanding under the Company’s plans during those years are as follows (number of shares in thousands):
|  | Years Ended December 31, |
|  | 2017 |  |  | 2016 |
|  | Number of Shares |  |  | Weighted Average Exercise Price |  |  | Number of Shares |  |  | Weighted Average Exercise Price |
Outstanding at beginning of year |  |  | 240 |  |  | $ | 4.18 |  |  |  | 240 |  |  | $ | 4.18 |
Exercised |  |  | (10 | ) |  |  | 3.74 |  |  |  | — |  |  |  | — |
Outstanding at end of year |  |  | 230 |  |  | $ | 4.18 |  |  |  | 240 |  |  | $ | 4.18 |
Options exercisable at end of year |  |  | 230 |  |  | $ | 4.18 |  |  |  | 240 |  |  | $ | 4.18 |
Stock options outstanding as of December 31, 2017 were as follows (number of shares in thousands):
|  |  |  |  | Options Outstanding |  |  |  | Options Exercisable |
| Range of Exercise Prices |  |  |  | Number Outstanding |  |  |  | Weighted Average Remaining Contractual Life (yrs.) |  |  |  | Weighted Average Exercise Price |  |  |  | Number Exercisable |  |  |  | Weighted Average Exercise Price |
$ | 3.74 |  |  |  | 219 |  |  |  | 5.47 |  |  | $ | 3.74 |  |  |  | 219 |  |  | $ | 3.74 |
$ | 12.90 |  |  |  | 11 |  |  |  | 3.59 |  |  | $ | 12.90 |  |  |  | 11 |  |  | $ | 12.90 |
The options outstanding at December 31, 2017 and 2016 had intrinsic values of $84,000 and $1,319,000, respectively. The intrinsic value of options exercised in 2017 was approximately $30,000. Restricted Stock – The Company granted to certain employees and directors shares of restricted stock under its 2006 and 2016 Stock Incentive Plans. A summary of unvested restricted stock activity is as follows (shares in thousands):
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
Unvested at December 31, 2014 |  |  | 390 |  |  | $ | 8.71 |
Issued |  |  | 307 |  |  | $ | 10.16 |
Vested |  |  | (220 | ) |  | $ | 7.94 |
Canceled |  |  | (14 | ) |  | $ | 10.08 |
Unvested at December 31, 2015 |  |  | 463 |  |  | $ | 10.00 |
Issued |  |  | 742 |  |  | $ | 5.24 |
Vested |  |  | (250 | ) |  | $ | 9.01 |
Canceled |  |  | (25 | ) |  | $ | 6.24 |
Unvested at December 31, 2016 |  |  | 930 |  |  | $ | 6.57 |
Issued |  |  | 664 |  |  | $ | 6.65 |
Vested |  |  | (480 | ) |  | $ | 7.30 |
Canceled |  |  | (37 | ) |  | $ | 6.08 |
Unvested at December 31, 2017 |  |  | 1,077 |  |  | $ | 6.31 |
The fair value of the common stock at vesting aggregated $3,210,000, $1,142,000 and $2,603,000 for the years ended December 31, 2017, 2016 and 2015, respectively. Stock-based compensation expense related to employee and non-employee restricted stock and option grants recognized in selling, general and administrative expenses, were as follows (in thousands):
|  | Years Ended December 31, |
|  | 2017 |  |  | 2016 |  |  | 2015 |
Employees |  | $ | 3,303 |  |  | $ | 2,173 |  |  | $ | 1,694 |
Non-employees |  |  | 525 |  |  |  | 443 |  |  |  | 325 |
Total stock-based compensation expense |  | $ | 3,828 |  |  | $ | 2,616 |  |  | $ | 2,019 |
Employee grants typically have a three year vesting schedule, while the non-employee grants have a one year vesting schedule. At December 31, 2017, the total compensation expense related to unvested awards which had not been recognized was $4,122,000 and the associated weighted-average period over which the compensation expense attributable to those unvested awards will be recognized was approximately 1.54 years.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration